Home to fast growing businesses
With a focus on therapeutics and world leading capabilities in cell and gene technologies.
Companies in our campus
-
Achilles Therapeutics is a biopharmaceutical company developing personalised T cell therapies targeting clonal neoantigens: protein markers unique to the individual ... -
Aglaris Ltd produce equipment to ensure cell and tissue culture is an easy, problem-free task. -
Autolus is founded on advanced cell programming technology pioneered by Dr Martin Pule and was spun-out from University College London ... -
The Cell and Gene Therapy Catapult was established in 2012 as an independent centre of excellence to advance… -
Cytiva formed through the divestiture of the GE Healthcare Biopharma business to Danaher Corporation in 2020. Cytiva is a global provider of technologies ... -
ImmTune Therapies is developing gene delivery vectors for specific modification of immune cells inside a patient’s body. Their ambition is ... -
Laverock Therapeutics is developing a unique gene silencing platform for the creation of programmable, allogeneic cell therapies. Laverock's differentiated technology ... -
MicrofluidX is tackling the problems of process control, scalability, and cost associated with cell bioprocessing, in particular for autologous cell ... -
Plasticell is developing therapies through precise manipulation of stem cells and more differentiated cell types using award-winning combinatorial screening technology. -
Quell Therapeutics is a UK based private biopharmaceutical company. Its vision is to be the leading engineered cell therapy company, ...
Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.
Learn moreCopyright © 2024 Stevenage Bioscience Catalyst
We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.